Ventana Biotech Inc
Ventana Global Inc. provides various portfolio of loans. The company offers custom financial, borrower and lender network, business advising and mentoring, and cash flow services. It also provides consulting services to third party businesses and individuals. The company was formerly known as Ventana Biotech, Inc. and changed its name to Ventana Global Inc. in January 2015. Ventana Global Inc. is… Read more
Ventana Biotech Inc (VNTA) - Net Assets
Latest net assets as of January 2025: $-53.93K USD
Based on the latest financial reports, Ventana Biotech Inc (VNTA) has net assets worth $-53.93K USD as of January 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($61.09K) and total liabilities ($115.02K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-53.93K |
| % of Total Assets | -88.28% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Ventana Biotech Inc - Net Assets Trend (2009–2025)
This chart illustrates how Ventana Biotech Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ventana Biotech Inc (2009–2025)
The table below shows the annual net assets of Ventana Biotech Inc from 2009 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-04-30 | $-52.33K | +27.54% |
| 2024-04-30 | $-72.22K | +13.19% |
| 2009-04-30 | $-83.20K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ventana Biotech Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4358800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (April 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $107.57K | % |
| Other Components | $74.56K | % |
| Total Equity | $-52.33K | 100.00% |
Ventana Biotech Inc Competitors by Market Cap
The table below lists competitors of Ventana Biotech Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Controladora Axtel S.A.B. de C.V.
PINK:CTLDF
|
$109.69 |
|
NAIROBI BUSINESS VENTURES LTD
XNAI:NBVL
|
$109.83 |
|
European Assets Trust PLC
LSE:EAT
|
$110.83 |
|
ZHONG AN REIT
BE:35Z
|
$111.06 |
|
National Reinsurance Corporation of the Philippines
PSE:NRCP
|
$109.45 |
|
BRAZILIAN METAL
BE:LR4
|
$109.36 |
|
Golden Prospect Precious Metals Ltd
LSE:GPM
|
$109.21 |
|
MALAWI PROPERTY INVESTMENT COMPANY
MSE:MPICO
|
$108.81 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ventana Biotech Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -72,224 to -52,334, a change of 19,890.
- Net income of 19,890 contributed positively to equity growth.
- Other factors decreased equity by 0.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $19.89K | +38.01% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Ventana Biotech Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-04-30 | $0.00 | $0.01 | x |
| 2009-04-30 | $-0.03 | $0.01 | x |
| 2024-04-30 | $0.00 | $0.01 | x |
| 2025-04-30 | $0.00 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ventana Biotech Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 48.09%
- • Asset Turnover: 0.67x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-161.59K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-38.76K |
| 2024 | 0.00% | 54.27% | 0.94x | 0.00x | $24.51K |
| 2025 | 0.00% | 48.09% | 0.67x | 0.00x | $25.12K |
Industry Comparison
This section compares Ventana Biotech Inc's net assets metrics with peer companies in the Credit Services industry.
Industry Context
- Industry: Credit Services
- Average net assets among peers: $42,167,772,618
- Average return on equity (ROE) among peers: 3.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ventana Biotech Inc (VNTA) | $-53.93K | 0.00% | N/A | $109.60 |
| Accord Financial Corp (ACCFF) | $103.96 Million | 11.43% | 4.00x | $8.00 Million |
| Acom Co. Ltd (ACJJF) | $306.73 Billion | 3.47% | 2.77x | $799.50 Million |
| Affirm Holdings Inc (AFRM) | $3.07 Billion | 1.70% | 2.63x | $13.28 Billion |
| Federal Agricultural Mortgage Corporation (AGM) | $47.20 Million | 1.69% | 11.77x | $1.51 Billion |
| Aiful Corp (AIFLF) | $97.47 Billion | -37.44% | 4.75x | $852.52 Million |
| Jianpu Technology Inc (AIJTY) | $520.74 Million | 20.38% | 0.93x | $16.37 Million |
| AIOS Tech Inc. (AIOS) | $40.53 Million | 17.61% | 0.35x | $2.83 Million |
| Ally Financial Inc (ALLY) | $13.49 Billion | 6.88% | 11.39x | $10.34 Billion |
| Alpha Investment Inc (ALPC) | $-38.66K | 0.00% | 0.00x | $166.69 Million |
| Antalpha Platform Holding Co (ANTA) | $202.32 Million | 9.14% | 10.90x | $14.83 Million |